Metropolitan Life Insurance Company (MetLife)’s Bristol-Myers Squibb BMY Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-82,067	Closed	-$4.45M	–	312
2024 Q1	$4.45M	Sell	82,067 -757	-0.9%	-$38.6K	0.19%	93
2023 Q4	$4.25M	Sell	82,824 -3,611	-4%	-$190K	0.2%	91
2023 Q3	$5.02M	Sell	86,435 -5,118	-6%	-$314K	0.26%	65
2023 Q2	$5.85M	Sell	91,553 -3,546	-4%	-$238K	0.28%	61
2023 Q1	$6.59M	Sell	95,099 -22,883	-19%	-$1.61M	0.34%	55
2022 Q4	$8.49M	Sell	117,982 -9,142	-7%	-$689K	0.38%	52
2022 Q3	$9.04M	Sell	127,124 -1,114	-0.9%	-$80.8K	0.43%	43
2022 Q2	$9.87M	Sell	128,238 -6,274	-5%	-$478K	0.43%	42
2022 Q1	$9.82M	Sell	134,512 -119,529	-47%	-$8.03M	0.35%	57
2021 Q4	$15.8M	Sell	254,041 -5,064	-2%	-$297K	0.22%	78
2021 Q3	$15.3M	Sell	259,105 -10,067	-4%	-$663K	0.22%	79
2021 Q2	$18M	Sell	269,172 -48,403	-15%	-$3.16M	0.25%	69
2021 Q1	$20M	Sell	317,575 -18,990	-6%	-$1.18M	0.3%	56
2020 Q4	$20.9M	Sell	336,565 -14,826	-4%	-$912K	0.31%	55
2020 Q3	$21.2M	Sell	351,391 -16,066	-4%	-$967K	0.36%	50
2020 Q2	$21.6M	Sell	367,457 -46,516	-11%	-$2.78M	0.38%	48
2020 Q1	$23.1M	Sell	413,973 -4,392	-1%	-$268K	0.47%	36
2019 Q4	$26.9M	Buy	418,365 +139,600	+50%	+$7.99M	0.43%	37
2019 Q3	$14.1M	Sell	278,765 -9,069	-3%	-$426K	0.24%	72
2019 Q2	$13.1M	Buy	287,834 +16,306	+6%	+$760K	0.22%	81
2019 Q1	$13M	Sell	271,528 -9,081	-3%	-$452K	0.23%	77
2018 Q4	$14.6M	Sell	280,609 -609	-0.2%	-$32.7K	0.29%	65
2018 Q3	$17.5M	Sell	281,218 -8,449	-3%	-$501K	0.3%	65
2018 Q2	$16M	Buy	289,667 +473	+0.2%	+$25.5K	0.26%	68
2018 Q1	$18.3M	Buy	289,194 +987	+0.3%	+$63.5K	0.26%	60
2017 Q4	$17.7M	Sell	288,207 -524,878	-65%	-$32.8M	0.23%	59
2017 Q3	$51.8M	Sell	813,085 -16,842	-2%	-$983K	0.32%	54
2017 Q2	$46.2M	Sell	829,927 -64,958	-7%	-$3.53M	0.32%	52
2017 Q1	$48.7M	Sell	894,885 -11,862	-1%	-$651K	0.34%	51
2016 Q4	$53M	Sell	906,747 -24,299	-3%	-$1.33M	0.38%	45
2016 Q3	$50.2M	Sell	931,046 -10,725	-1%	-$689K	0.37%	49
2016 Q2	$69.3M	Sell	941,771 -8,473	-0.9%	-$599K	0.51%	36
2016 Q1	$60.7M	Sell	950,244 -14,488	-2%	-$914K	0.47%	41
2015 Q4	$66.4M	Sell	964,732 -12,795	-1%	-$846K	0.51%	35
2015 Q3	$57.9M	Sell	977,527 -16,331	-2%	-$1.04M	0.42%	43
2015 Q2	$66.1M	Buy	993,858 +49,003	+5%	+$3.23M	0.46%	39
2015 Q1	$60.9M	Sell	944,855 -10,392	-1%	-$651K	0.45%	41
2014 Q4	$56.4M	Sell	955,247 -2,338	-0.2%	-$132K	0.39%	46
2014 Q3	$49M	Sell	957,585 -14,169	-1%	-$708K	0.35%	50
2014 Q2	$47.1M	Sell	971,754 -71,531	-7%	-$3.53M	0.33%	51
2014 Q1	$54.2M	Sell	1,043,285 -17,293	-2%	-$920K	0.38%	47
2013 Q4	$56.4M	Sell	1,060,578 -22,744	-2%	-$1.16M	0.4%	44
2013 Q3	$50.1M	Sell	1,083,322 -5,919	-0.5%	-$260K	0.38%	44
2013 Q2	$48.7M	Buy	+1,089,241	New	+$47.3M	0.39%	41

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s BMY Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 82,067 shares — an estimated $4.45M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in BMY in Q2 2013 and held it in 44 quarters. The position peaked at $69.3M in Q2 2016. 2,149 funds tracked by Wall St. Rank hold BMY as of Q2 2024.

Metropolitan Life Insurance Company (MetLife) reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 82,067 Bristol-Myers Squibb shares in Q2 2024, an estimated $4.45M.
Metropolitan Life Insurance Company (MetLife) first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 44 quarters.
Metropolitan Life Insurance Company (MetLife)'s Bristol-Myers Squibb position peaked at $69.3M in Q2 2016.
2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.